For the overall survival analysis, with the aid of cohort from GSE14520, we established a risk signature with two prognostic hub genes: TOP2A and KIF11, which was demonstrated to be an independent prognostic predictor for HBV-HCC patient by univariate and multivariate analyses and was significantly correlated with tumor staging systems and AFP levels. This evidence concerns the gene TOP2A and neoplasm.